Vigamox

DRUG5 trials

Sponsors

Alcon Research, Illinois Retina Associates, Ophthalmology Consultants, Ltd., Laboratorios Sophia S.A de C.V., Washington University School of Medicine

Conditions

Bacterial ConjunctivitisCataract SurgeryCorneal HealthIntravitreal Injection PatientsOcular Graft-versus-host Disease

Phase 2

Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)

CompletedNCT02980523

Laboratorios Sophia S.A de C.V.Bacterial Conjunctivitis

Start: 2015-03-31End: 2017-05-31Updated: 2019-05-22

Vigamox Treatment for Ocular Graft-Versus-Host Disease

WithdrawnNCT04204122

Washington University School of MedicineOcular Graft-versus-host Disease

Start: 2020-06-15End: 2025-03-31Updated: 2023-08-08

Phase 4

Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

CompletedNCT00312338

Alcon ResearchBacterial Conjunctivitis

Start: 2006-06-30End: 2007-06-30Updated: 2012-11-02

Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections

CompletedNCT00690313

Illinois Retina AssociatesIntravitreal Injection Patients

Start: 2008-08-31End: 2011-04-30Updated: 2019-08-07

2-Site Safety Study of Besivance Versus Vigamox Prophylactically in Routine Cataract Surgery

CompletedNCT01455233

Ophthalmology Consultants, Ltd.Cataract Surgery, Corneal Health

Start: 2010-09-30End: 2011-02-28Updated: 2011-10-19